Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide
暂无分享,去创建一个
D. Amadori | V. Conteduca | U. de Giorgi | L. Rossi | E. Bianchi | E. Carretta | S. Burgio | C. Menna | C. Masini
暂无分享,去创建一个
D. Amadori | V. Conteduca | U. de Giorgi | L. Rossi | E. Bianchi | E. Carretta | S. Burgio | C. Menna | C. Masini